China Resources Pharmaceutical Group Ltd.
3320
Classement en actions
#4342
China Resources Pharmaceutical Group Limited, an investment holding company,... China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Prix de l'action
$0.57730615
Capitalisation boursière
$3.63B
Changement (1 jour)
-3.05%
Changement (1 an)
-6.33%
Pays
HK
Échange China Resources Pharmaceutical Group Ltd. (3320)
Catégorie
Healthcare
Revenus pour China Resources Pharmaceutical Group Ltd. (3320)
Revenus en Jun 2026 TTM : $39.21B
Selon les derniers rapports financiers de China Resources Pharmaceutical Group Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de $39.21B. En 2023, l'entreprise a réalisé un chiffre d'affaires de $34.63B une augmentation par rapport à le chiffre d'affaires de l'année 2022, qui était de $32.52B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour China Resources Pharmaceutical Group Ltd. de 2013 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $39.21B | 11.04% |
| 2024 | $35.32B | 1.99% |
| 2023 | $34.63B | 6.47% |
| 2022 | $32.52B | 7.07% |
| 2021 | $30.37B | 17.51% |
| 2020 | $25.85B | -1.53% |
| 2019 | $26.25B | 8.39% |
| 2018 | $24.22B | 9.67% |
| 2017 | $22.08B | 9.26% |
| 2016 | $20.21B | 6.88% |
| 2015 | $18.91B | 8.04% |
| 2014 | $17.50B | 16.05% |
| 2013 | $15.08B | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $2.54B | -93.53% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $830.81M | -97.88% |
US
|
|
| - | - |
IT
|
